Abstract
No public abstract is available from the verified source records.
Wiert F. Hoeksema, José S.A. Belderbos, Edith M.T. Dieleman, Krista van Doorn-Wink, H A C M De Bruin-Bon, Martijn Hendrik van der Ree, Jorrit Visser, Luuk H G A Hopman, Z. van Kesteren, Pieter G. Postema, R Planken, Jan‐Jakob Sonke, Barbara Stam
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1016/s1470-2045(14)71207-0
10.1016/s1470-2045(14)71207-0 · 2015
Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients
10.1016/j.radonc.2017.04.017 · 2017
Radiation dose to heart base linked with poorer survival in lung cancer patients
10.1016/j.ejca.2017.07.053 · 2017
Cardiac maximum point dose predicts for patient survival in early stage non–small cell lung cancer patients treated with stereotactic body radiation therapy
10.1016/j.ijrobp.2017.06.585 · 2017
Impact of cardiac dose on overall survival in lung stereotactic body radiotherapy (SBRT) compared to conventionally fractionated radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC)
10.4236/jct.2021.127036 · 2021
The association of incidental radiation dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for non-small cell lung cancer: Results from the NI-HEART study
10.1016/j.clon.2023.11.029 · 2024
Cardiac events after radiation therapy: Combined analysis of prospective multicenter trials for locally advanced non–small-cell lung cancer
10.1200/jco.2016.71.6142 · 2017
Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
10.1016/j.ijrobp.2017.05.022 · 2017
Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non–small cell lung cancer
10.1001/jamaoncol.2020.6332 · 2021
Dual effect of radiotherapy related concomitant cardiovascular diseases in non-small cell lung cancer
10.1002/cam4.4948 · 2022
The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer
10.1016/j.ijrobp.2017.04.026 · 2017
Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer
10.1001/jamaoncol.2022.4202 · 2022
Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer
10.1016/j.jacc.2019.03.500 · 2019
Past, present, and future of radiation-induced cardiotoxicity: Refinements in targeting, surveillance, and risk stratification
10.1016/j.jaccao.2021.06.007 · 2021
Cardiotoxicity following thoracic radiotherapy for lung cancer
10.1038/s41416-024-02888-0 · 2025
Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer
10.1016/j.cllc.2019.05.014 · 2019
Risk of cardiovascular disease from cumulative cigarette use and the impact of smoking intensity
10.1097/ede.0000000000000437 · 2016
Unresolved referenced work
Kept as external metadata until matched
Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer
10.1016/j.ijrobp.2009.10.058 · 2011
Determination and interpretation of the QT interval
10.1161/circulationaha.118.033943 · 2018
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association
10.1161/hc0402.102975 · 2002
Normal ranges of left ventricular strain: A meta-analysis
10.1016/j.echo.2012.10.008 · 2013
Standardizing the cardiac radioablation targeting workflow: Enabling semi-automated angulation and segmentation of the heart according to the American Heart Association segmented model
2022
Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: A systematic review and meta-analysis
10.1001/jamacardio.2019.2952 · 2019
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis
10.1016/j.radonc.2021.01.034 · 2021
Inter-technique agreement of left atrial and ventricular deformation analysis: A comparison between transthoracic echocardiography and cardiovascular magnetic resonance imaging
10.1186/s44156-025-00090-3 · 2025
Assessment of myocardial deformation with CMR: A comparison with ultrasound speckle tracking
10.1007/s00330-021-07857-2 · 2021
Prognostic implications of global LV dysfunction: A systematic review and meta-analysis of global longitudinal strain and ejection fraction
10.1136/heartjnl-2014-305538 · 2014
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
10.1093/eurheartj/ehac244 · 2022
Quantitative analysis of radiation therapy-induced cardiac and aortic sequelae in patients with lung cancer via magnetic resonance imaging: A pilot study
10.1016/j.ijrobp.2023.10.037 · 2023
Changes in cardiac function in patients receiving radiation therapy for lung cancer
10.1016/j.jtho.2026.01.002 · 2026
Dose-dependent cardiac effects of collateral cardiac irradiation: Echocardiographic strain analysis in patients treated for extracardiac malignancies
10.1016/j.hrthm.2022.09.002 · 2023
Dose-dependent cardiac effects of collateral cardiac irradiation: Echocardiographic strain analysis in patients treated for extracardiac malignancies
10.1016/j.hrthm.2022.09.002 · doi-reference
Changes in cardiac function in patients receiving radiation therapy for lung cancer
10.1016/j.jtho.2026.01.002 · doi-reference
Quantitative analysis of radiation therapy-induced cardiac and aortic sequelae in patients with lung cancer via magnetic resonance imaging: A pilot study
10.1016/j.ijrobp.2023.10.037 · doi-reference
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
10.1093/eurheartj/ehac244 · doi-reference
Prognostic implications of global LV dysfunction: A systematic review and meta-analysis of global longitudinal strain and ejection fraction
10.1136/heartjnl-2014-305538 · doi-reference
Assessment of myocardial deformation with CMR: A comparison with ultrasound speckle tracking
10.1007/s00330-021-07857-2 · doi-reference
Inter-technique agreement of left atrial and ventricular deformation analysis: A comparison between transthoracic echocardiography and cardiovascular magnetic resonance imaging
10.1186/s44156-025-00090-3 · doi-reference
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis
10.1016/j.radonc.2021.01.034 · doi-reference
Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: A systematic review and meta-analysis
10.1001/jamacardio.2019.2952 · doi-reference
Normal ranges of left ventricular strain: A meta-analysis
10.1016/j.echo.2012.10.008 · doi-reference
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association
10.1161/hc0402.102975 · doi-reference
Determination and interpretation of the QT interval
10.1161/circulationaha.118.033943 · doi-reference
Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer
10.1016/j.ijrobp.2009.10.058 · doi-reference
Risk of cardiovascular disease from cumulative cigarette use and the impact of smoking intensity
10.1097/ede.0000000000000437 · doi-reference
Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer
10.1016/j.cllc.2019.05.014 · doi-reference
Cardiotoxicity following thoracic radiotherapy for lung cancer
10.1038/s41416-024-02888-0 · doi-reference
Past, present, and future of radiation-induced cardiotoxicity: Refinements in targeting, surveillance, and risk stratification
10.1016/j.jaccao.2021.06.007 · doi-reference
Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer
10.1016/j.jacc.2019.03.500 · doi-reference
Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer
10.1001/jamaoncol.2022.4202 · doi-reference
The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer
10.1016/j.ijrobp.2017.04.026 · doi-reference
Dual effect of radiotherapy related concomitant cardiovascular diseases in non-small cell lung cancer
10.1002/cam4.4948 · doi-reference
Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non–small cell lung cancer
10.1001/jamaoncol.2020.6332 · doi-reference
Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer
10.1016/j.ijrobp.2017.05.022 · doi-reference
Cardiac events after radiation therapy: Combined analysis of prospective multicenter trials for locally advanced non–small-cell lung cancer
10.1200/jco.2016.71.6142 · doi-reference
The association of incidental radiation dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for non-small cell lung cancer: Results from the NI-HEART study
10.1016/j.clon.2023.11.029 · doi-reference
Impact of cardiac dose on overall survival in lung stereotactic body radiotherapy (SBRT) compared to conventionally fractionated radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC)
10.4236/jct.2021.127036 · doi-reference
Cardiac maximum point dose predicts for patient survival in early stage non–small cell lung cancer patients treated with stereotactic body radiation therapy
10.1016/j.ijrobp.2017.06.585 · doi-reference
Radiation dose to heart base linked with poorer survival in lung cancer patients
10.1016/j.ejca.2017.07.053 · doi-reference
Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients
10.1016/j.radonc.2017.04.017 · doi-reference
10.1016/s1470-2045(14)71207-0
10.1016/s1470-2045(14)71207-0 · doi-reference